Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index.
Sergio Raposeiras-RoubinJose Antonio Parada BarciaAndrea Lizancos CastroVanessa Noriega CaroAna Ledo PiñeiroInmaculada González BermúdezRocío González FerreiroAndrés Íñiguez-RomoEmad Abu-AssiPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
The FIB-4 index, a non-invasive scoring method for evaluating liver fibrosis, is independently associated with all-cause mortality, MB and HF in patients with AF, suggesting that it may be useful as a risk assessment tool to identify adverse outcomes in patients with AF.
Keyphrases
- liver fibrosis
- atrial fibrillation
- catheter ablation
- oral anticoagulants
- left atrial
- left atrial appendage
- direct oral anticoagulants
- heart failure
- percutaneous coronary intervention
- type diabetes
- coronary artery disease
- acute heart failure
- metabolic syndrome
- adipose tissue
- acute coronary syndrome
- left ventricular
- glycemic control
- weight loss